血管干扰剂和电离辐射联合

Article Outline

• Abstract
• 1. Vascular disrupting agents
  • 1.1. Antiangiogenic and vascular disrupting agents
  • 1.2. Microtubule-binding and vascular disrupting agents: a question of dose?
    • 1.2.1. A classification based upon experimental observations
    • 1.2.2. Antiproliferative effects
    • 1.2.3. Antivascular effects
  • 1.3. Clinical efficacy and safety of vascular disrupting agents in humans
• 2. Combination of vascular disrupting agents and irradiation
  • 2.1. Rationale for the combination
  • 2.2. Results
• 3. New molecules
• 4. Conclusion
• Con
  
  

  上一篇： 矩阵辅助激光解吸附/离子化，基于时间飞跃质谱血液组基因分型——备选方法

  下一篇： 骨髓及外骨髓增殖新生物分子诊断： JAK2 V617F和相关突变检测英国指导原则

  学科代码：肿瘤学　　　关键词：Vascular disrupting agents Radiotherapy CA-4-P Tubulin binding agents Antiangiogenic agents Preclinical rationale
  来源： Critical Reviews In Oncology Hematology
  顶一下（0）